Breakthroughs in cancer research and the revolutionary role of gold in cancer treatment – The Babak Lab
The Babak Lab shared a post on LinkedIn:
”Breakthroughs in Cancer Research and Revolutionary Use of Gold.
This week brings exciting advancements in cancer research and the revolutionary role of gold in cancer treatment. Here’s why you shouldn’t miss out:
Translational Cancer Dependency Map – Paving the Future of Targeted Therapies.
A study published in Nature Portfolio introduces a groundbreaking translational cancer dependency map. This tool uses machine learning to identify tumor vulnerabilities and predict patient outcomes, marking a shift in personalized cancer therapies.
Why read?
- Learn how cutting-edge models pinpoint new therapeutic targets.
- Discover how this map can guide drug development and improve patient outcomes.
AI-driven Breast Cancer Prognosis with kla-related lncRNA Signature.
A breakthrough study has identified lncRNA signatures that could reshape breast cancer prognosis. Using AI (XGBoost), the research offers better stratification of high-risk patients, opening doors for personalized treatments.
Why read?
- Explore AI’s role in tailoring immune therapies for breast cancer.
- Understand how tumor mutation burden could guide better treatments.
Gold’s Versatility in Cancer Treatment.
This post uncovers gold’s role beyond luxury. Gold nanoparticles are now used to target cancer cells more precisely, reducing side effects and improving diagnostics.
Why read?
- Find out how ancient materials like gold are used in cutting-edge cancer therapy.
- Understand gold’s potential to revolutionize cancer diagnostics and treatment.
Whether it’s innovative maps, AI in breast cancer prognosis, or gold in treatment, these breakthroughs push the boundaries of cancer research. Dive in to stay ahead in the evolving world of medical innovations.”
Maria (Masha) Babak shared a post by The Babak Lab, on LinkedIn, adding:
”This week The Babak Lab dived into exciting breakthroughs in cancer research, including AI-powered breast cancer prognosis and the innovative use of gold nanoparticles for targeted therapies. The future of precision medicine is closer than ever! If you’re curious about how AI and nanotechnology are changing the healthcare landscape, you should definitely check this out.
What role do you think AI will play in cancer treatments moving forward? And how could materials like gold reshape our approach to therapy? Share your thoughts! ”
Source: The Babak Lab/LinkedIn and Maria (Masha) Babak/LinkedIn
Maria (Masha) Babak is the Head of The Babak Lab and an Assistant Professor at the City University of Hong Kong. In November 2020, she joined the City University of Hong Kong as an assistant professor. Dr. Babak received the Graeme Hanson-AsBIC Early Career Award in 2022.
Her research interests are at the intersection of chemistry, biology, and medicine, with a focus on the discovery and preclinical development of anticancer drugs for resistant and aggressive cancers with limited treatment options, such as malignant pleural mesothelioma and brain metastases.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023